Background Decisions about driving cessation can be stressful for older adults. We tested effects of a driving decision aid (DDA) on psychosocial outcomes among older drivers during two-year follow-…
Imlunestrant is a next-generation, brain-penetrant, oral selective estrogen-receptor (ER) degrader that delivers continuous ER inhibition, even in cancers with mutations in the gene encoding ERα…
As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go uncontested.
Objectives This study aimed to explore the prevalence of medication non-adherence and influence of symptom perception and various barriers on medication adherence among Thai Muslim…
Doctors from Syria who work for the NHS have told The BMJ about “Holocaust-like” scenes that have unfolded at the liberated Saydnaya military prison 18…
Falnikar et al. report that the nucleoporin Nup153, a binding partner of microtubule motor protein Kif1a, originally identified in a proteomic study, recruits Kif1a to the…
Background Sleep is essential for the recovery of patients with disorders of consciousness (DoC). However, few approaches targeting sleep were applied. Melatonin has been shown…
A law firm alleging Anthem deliberately includes out-of-network providers in its directories is eyeing UnitedHealthcare, Aetna and other insurers.
Your story may hold no relevance for anyone else and may come off more like marketing than journalism
This review focuses on DRESS, a serious drug-induced T-cell–mediated condition with marked cutaneous and systemic effects.
Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet syndrome.
